Sign up to save your podcasts
Or
Share Progentec Raises $5M in Series A
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Progentec Raises $5M in Series A
Tweet OKLAHOMA CITY, OK, Progentec has completed a $5 million Series A funding round.
The funding round provides go-to-market capital for Progentec's CLIA laboratory and digital technologies for the management of lupus.
"In early 2020, Progentec will launch the aiSLE DX biomarker assay for early prediction of lupus flares.
Later this year, Progentec will launch an enhanced lupus disease diagnosis assay to correctly diagnose/classify lupus patients.
This funding will also support new research into digital biomarkers and remote delivery of digital therapeutic programs. | To read full story, visit https://startuparound.com/read/1578528010.9965656/Progentec-Raises-$5M-in-Series-A?ref=audio_experience
View all episodes
By Startup AroundTweet OKLAHOMA CITY, OK, Progentec has completed a $5 million Series A funding round.
The funding round provides go-to-market capital for Progentec's CLIA laboratory and digital technologies for the management of lupus.
"In early 2020, Progentec will launch the aiSLE DX biomarker assay for early prediction of lupus flares.
Later this year, Progentec will launch an enhanced lupus disease diagnosis assay to correctly diagnose/classify lupus patients.
This funding will also support new research into digital biomarkers and remote delivery of digital therapeutic programs. | To read full story, visit https://startuparound.com/read/1578528010.9965656/Progentec-Raises-$5M-in-Series-A?ref=audio_experience